Stifel Financial Corp Has $17.31 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Stifel Financial Corp grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 5.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 156,655 shares of the company's stock after purchasing an additional 7,716 shares during the quarter. Stifel Financial Corp owned approximately 0.06% of Cardinal Health worth $17,313,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Point72 Asset Management L.P. acquired a new stake in Cardinal Health during the 2nd quarter worth $90,440,000. Pacer Advisors Inc. grew its stake in shares of Cardinal Health by 9.9% during the second quarter. Pacer Advisors Inc. now owns 4,099,082 shares of the company's stock worth $403,022,000 after purchasing an additional 370,181 shares during the period. Caisse DE Depot ET Placement DU Quebec increased its holdings in Cardinal Health by 230.0% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company's stock valued at $52,819,000 after purchasing an additional 333,095 shares during the last quarter. Wedge Capital Management L L P NC bought a new stake in Cardinal Health in the third quarter valued at about $30,820,000. Finally, American Century Companies Inc. lifted its stake in Cardinal Health by 17.7% in the second quarter. American Century Companies Inc. now owns 1,610,968 shares of the company's stock valued at $158,390,000 after buying an additional 242,608 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Stock Down 1.0 %

Shares of NYSE CAH traded down $1.16 during trading hours on Tuesday, hitting $120.42. The company had a trading volume of 1,303,789 shares, compared to its average volume of 2,098,135. The stock has a market capitalization of $29.14 billion, a P/E ratio of 23.66, a price-to-earnings-growth ratio of 1.53 and a beta of 0.61. The firm's 50 day moving average is $116.51 and its 200-day moving average is $107.90. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $126.23.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The company had revenue of $52.28 billion for the quarter, compared to analysts' expectations of $50.90 billion. During the same period in the prior year, the firm earned $1.73 EPS. Cardinal Health's quarterly revenue was down 4.3% compared to the same quarter last year. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.

Cardinal Health Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.5056 per share. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.68%. Cardinal Health's dividend payout ratio is currently 39.30%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CAH. Evercore ISI lifted their price objective on shares of Cardinal Health from $105.00 to $115.00 and gave the stock an "in-line" rating in a research note on Thursday, August 15th. Robert W. Baird lifted their price target on shares of Cardinal Health from $130.00 to $137.00 and gave the stock an "outperform" rating in a research report on Thursday, August 15th. Argus increased their price target on Cardinal Health from $115.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, September 11th. Mizuho assumed coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They set an "outperform" rating and a $139.00 price objective on the stock. Finally, JPMorgan Chase & Co. upped their price objective on Cardinal Health from $111.00 to $123.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 21st. One analyst has rated the stock with a sell rating, four have assigned a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $124.58.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.